The FDA has accepted for review the resubmitted BLA for prademagene zamikeracel for recessive dystrophic epidermolysis bullosa.

Denali Therapeutics' innovative approach to neurological disorders and strong financial strategy position it as a leader in ...

Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke ...

Philippines President Ferdinand Marcos Jr directed authorities on Friday to stock up on food and other supplies in advance as Typhoon Man-yi threatened to hit the capital region. Asia ...